Risk Factors for Failure of Pavlik Harness Treatment in Infants With Dislocated Hips That Are Evaluated by Dynamic Sonography.


Journal

Journal of pediatric orthopedics
ISSN: 1539-2570
Titre abrégé: J Pediatr Orthop
Pays: United States
ID NLM: 8109053

Informations de publication

Date de publication:
01 Jul 2021
Historique:
entrez: 7 6 2021
pubmed: 8 6 2021
medline: 10 7 2021
Statut: ppublish

Résumé

Frankly dislocated hips occur in ∼1% to 3% of infants with developmental dysplasia of the hip and are often difficult to treat. In the most severely dislocated hips, the femoral head is positioned outside the posterior/lateral rim of the acetabulum and is irreducible, that is, the femoral head will not reduce by positioning the leg. The purpose of this study was to determine risk factors, using univariate and multivariate analyses, for Pavlik harness failure in infants who initially presented with irreducible/dislocated hips (confirmed by dynamic sonography). Following institutional review board approval, 124 infants (170 hips) with frankly dislocated hips treated using a Pavlik harness between 2000 and 2018 were evaluated. Patients' demographic characteristics, clinical findings, dynamic sonographic findings (dislocated-fixed vs. dislocated-mobile), age at onset of Pavlik harness treatment, duration of harness usage, and follow-up treatments were recorded. Univariate analyses were used to determine risk factors for treatment failure. In frankly dislocated hips (confirmed by dynamic sonography to be positioned outside the posterior/lateral rim of the acetabulum), Pavlik harness treatment was successful in 104 of 170 hips (61%) while it failed in 66 hips. Mean follow-up was 4.86±4.20 years. Univariate analysis determined the risk factors to be onset of treatment after the seventh week of age (P=0.049) and initial mobility (dislocated-fixed group) (P<0.001) by dynamic sonography. In addition, multivariate analysis (P=0.007) showed infants of multigravida mothers (non-firstborn) to be another risk factor for failure. Six percent of hips with no risk factors failed Pavlik harness treatment, those with 1 risk factor had 42% failure, 2 risk factors had 69% failure, and all 3 risk factors had 100% failure. In our patients with frankly dislocated irreducible hips, 39% of hip failed Pavlik harness treatment. Independent multivariate, logistic regression analysis, and multivariate analysis determining the risk factors for failure of Pavlik harness treatment were onset of treatment after the seventh week of age, infants of multigravida mothers, and initial hip mobility (fixed-dislocated hips) by dynamic sonography. Level III.

Sections du résumé

BACKGROUND BACKGROUND
Frankly dislocated hips occur in ∼1% to 3% of infants with developmental dysplasia of the hip and are often difficult to treat. In the most severely dislocated hips, the femoral head is positioned outside the posterior/lateral rim of the acetabulum and is irreducible, that is, the femoral head will not reduce by positioning the leg. The purpose of this study was to determine risk factors, using univariate and multivariate analyses, for Pavlik harness failure in infants who initially presented with irreducible/dislocated hips (confirmed by dynamic sonography).
METHODS METHODS
Following institutional review board approval, 124 infants (170 hips) with frankly dislocated hips treated using a Pavlik harness between 2000 and 2018 were evaluated. Patients' demographic characteristics, clinical findings, dynamic sonographic findings (dislocated-fixed vs. dislocated-mobile), age at onset of Pavlik harness treatment, duration of harness usage, and follow-up treatments were recorded. Univariate analyses were used to determine risk factors for treatment failure.
RESULTS RESULTS
In frankly dislocated hips (confirmed by dynamic sonography to be positioned outside the posterior/lateral rim of the acetabulum), Pavlik harness treatment was successful in 104 of 170 hips (61%) while it failed in 66 hips. Mean follow-up was 4.86±4.20 years. Univariate analysis determined the risk factors to be onset of treatment after the seventh week of age (P=0.049) and initial mobility (dislocated-fixed group) (P<0.001) by dynamic sonography. In addition, multivariate analysis (P=0.007) showed infants of multigravida mothers (non-firstborn) to be another risk factor for failure. Six percent of hips with no risk factors failed Pavlik harness treatment, those with 1 risk factor had 42% failure, 2 risk factors had 69% failure, and all 3 risk factors had 100% failure.
CONCLUSIONS CONCLUSIONS
In our patients with frankly dislocated irreducible hips, 39% of hip failed Pavlik harness treatment. Independent multivariate, logistic regression analysis, and multivariate analysis determining the risk factors for failure of Pavlik harness treatment were onset of treatment after the seventh week of age, infants of multigravida mothers, and initial hip mobility (fixed-dislocated hips) by dynamic sonography.
LEVEL OF EVIDENCE METHODS
Level III.

Identifiants

pubmed: 34096546
doi: 10.1097/BPO.0000000000001799
pii: 01241398-202107000-00007
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e386-e391

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Harding MG, Harcke HT, Bowen JR, et al. Management of dislocated hips with Pavlik harness treatment and ultrasound monitoring. J Pediatr Orthop. 1997;17:189–198.
Ömeroğlu H, Köse N, Akceylan A. Success of Pavlik harness treatment decreases in patients ≥4 months and in ultrasonographically dislocated hips in developmental dysplasia of the hip. Clin Orthop Relat Res. 2016;474:1146–1152.
Pavlik A. Stirrups as an aid in the treatment of congenital dysplasia of the hip in children. By Arnold Pavlik, 1950. J Pediatr Orthop. 1989;9:157–159.
Ramsey PL, Lasser S, MacEwen GD. Congenital dislocation of the hip. Use of the Pavlik harness in the child during the first six months of life. J Bone Joint Surg Am. 1976;58:1000–1004.
Mubarak SJ, Bialik V. Pavlik: the man and his method. J Pediatr Orthop. 2003;23:342–346.
Atalar H, Sayli U, Yavuz OY, et al. Indicators of successful use of the Pavlik harness in infants with developmental dysplasia of the hip. Int Orthop. 2007;31:145–150.
Lerman JA, Emans JB, Millis MB, et al. Early failure of Pavlik harness treatment for developmental hip dysplasia: clinical and ultrasound predictors. J Pediatr Orthop. 2001;21:348–353.
Viere RG, Birch JG, Herring JA, et al. Use of the Pavlik harness in congenital dislocation of the hip. An analysis of failures of treatment. J Bone Joint Surg Am. 1990;72:238–244.
Borowski A, Thawrani D, Grissom L, et al. Bilaterally dislocated hips treated with the Pavlik harness are not at a higher risk for failure. J Pediatr Orthop. 2009;29:661–665.
Vadillo P, Encinas-Ullan CA, Moraleda L, et al. Results of the Pavlik harness when treating Ortolani-positive hips: predictors of failure and arthrographic findings. J Child Orthop. 2015;9:249–253.
Inoue T, Naito M, Nomiyama H. Treatment of developmental dysplasia of the hip with the Pavlik harness: factors for predicting unsuccessful reduction. J Pediatr Orthop B. 2001;10:186–191.
Upasani VV, Bomar JD, Matheney TH, et al. Evaluation of brace treatment for infant hip dislocation in a prospective cohort: defining the success rate and variables associated with failure. J Bone Joint Surg Am. 2016;98:1215–1221.
Kitoh H, Kawasumi M, Ishiguro N. Predictive factors for unsuccessful treatment of developmental dysplasia of the hip by the Pavlik harness. J Pediatr Orthop. 2009;29:552–557.
Borges JL, Kumar SJ, Guille JT. Congenital dislocation of the hip in boys. J Bone Joint Surg Am. 1995;77:975–984.
Peled E, Bialik V, Katzman A, et al. Treatment of Graf’s ultrasound class III and IV hips using Pavlik’s method. Clin Orthop Relat Res. 2008;466:825–829.
White KK, Sucato DJ, Agrawal S, et al. Ultrasonographic findings in hips with a positive Ortolani sign and their relationship to Pavlik harness failure. J Bone Joint Surg Am. 2010;92:113–120.
Aarvold A, Schaeffer EK, Kelley S, et al. Management of irreducible hip dislocations in infants with developmental dysplasia of the hip diagnosed below 6 months of age. J Pediatr Orthop. 2019;39:e39–e43.
Palocaren T, Rogers K, Haumont T, et al. High failure rate of the Pavlik harness in dislocated hips: is it bilaterality? J Pediatr Orthop. 2013;33:530–535.
Harcke HT, Grissom LE. Performing dynamic sonography of the infant hip. AJR Am J Roentgenol. 1990;155:837–844.
Kalamchi A, MacEwen GD. Avascular necrosis following treatment of congenital dislocation of the hip. J Bone Joint Surg Am. 1980;62:876–888.
R Core Team. R: A Language and Environment for Statistical Computing R Foundation for Statistical Computing. Vienna, Austria: R Core Team. Available at: https://www.R-project.org/ . Accessed January 9, 2020.
Novais EN, Kestel LA, Carry PM, et al. Higher Pavlik harness treatment failure is seen in Graf type IV Ortolani-positive hips in males. Clin Orthop Relat Res. 2016;474:1847–1854.
Mostert AK, Tulp NJ, Castelein RM. Early failure of Pavlik harness treatment of developmental hip dysplasia: clinical and ultrasound predictors. J Pediatr Orthop. 2002;22:410; discussion 410.
Hines AC, Neal DC, Beckwith T, et al. A comparison of Pavlik harness treatment regimens for dislocated but reducible (Ortolani+) hips in infantile developmental dysplasia of the hip. J Pediatr Orthop. 2019;39:505–509.
Swaroop VT, Mubarak SJ. Difficult-to-treat Ortolani-positive hip: improved success with new treatment protocol. J Pediatr Orthop. 2009;29:224–230.
Suzuki S, Yamamuro T. Avascular necrosis in patients treated with the Pavlik harness for congenital dislocation of the hip. J Bone Joint Surg Am. 1990;72:1048–1055.

Auteurs

Ahmet Imerci (A)

Department of Orthopaedic Surgery, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.
Department of Orthopaedics and Traumatology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey.

Kenneth J Rogers (KJ)

Department of Orthopaedic Surgery, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

Abhishek Bhattacharjee (A)

Biomedical Research, Nemours Children's Health System, Jacksonville, FL.

James Richard Bowen (JR)

Department of Orthopaedic Surgery, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

Mihir M Thacker (MM)

Department of Orthopaedic Surgery, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH